The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep Diseases
心脏、肺、血液和睡眠疾病护理点推进中心
基本信息
- 批准号:10222761
- 负责人:
- 金额:$ 156.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-22 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAffectAmericanAutomobile DrivingBloodBusinessesCardiovascular systemCaregiversCaringCessation of lifeClinicClinicalDetectionDevelopmentDevice or Instrument DevelopmentDiagnosisDiseaseEngineeringFamily CaregiverFeedbackFundingGoalsHealthHealthcareHeartHeart DiseasesHeart failureHematological DiseaseIncomeIncubatorsInterventionKnowledgeLeadLifeLungLung diseasesMassachusettsMedicalMedical DeviceMentorsModelingMonitorMorbidity - disease rateOutpatientsParticipantPathway interactionsPatientsPhysiciansPoint of Care TechnologyPolicy MakerPreventive measureProcessProviderQuality of lifeReportingResourcesRoleSelf CareSleepSleep DisordersSymptomsSystemTechnologyTimeTrainingTraining ProgramsUniversitiesVisionacute carebundled paymentclinical developmentcommercializationcostevidence basehospital readmissionhypertension controlimprovedindustry partnermedical schoolsmortalitynovelpoint of careprecision medicineprogramsresearch clinical testingsuccesstechnology developmenttooltrenduser-friendly
项目摘要
PROJECT SUMMARY/ABSTRACT - OVERALL
American healthcare is rapidly evolving to a state where efficiency and quality in health care are
co-dominant drivers. Several emergent trends are driving fundamental changes in health care:
1) increasing numbers of patients in accountable care organizations with bundled payments to
providers; 2) emphasis on quality metrics such as reducing readmissions for heart failure and
improving control of hypertension; and 3) increasing focus on the patient as a driver of medical
decisions and a partner in care. There is now an urgent need to develop technologies that
provide rapid feedback to both caregivers and patients in order to effect timely changes in
patient self-care, symptom detection, diagnosis and treatment delivery. In particular, there is a
critical need for new evidence-based, user-friendly, patient-centric, point-of-care technologies
(POCT) to monitor health/medical status in people as they go about their daily lives out of the
clinic and to deliver actionable reports to the point of care. The Center for Advancing Point of
Care Technologies (CAPCaT) in Heart, Lung, Blood, and Sleep Diseases will be an offshoot of
a highly successful medical product incubator, the Massachusetts Medical Device Development
Center (M2D2) at the University of Massachusetts (Lowell and Worcester campuses). The
founding goal of M2D2 was to accelerate the development of medical devices, using the
combined expertise of UMass Lowell (UML) in engineering and business, and the clinical
expertise of UMass Medical School (UMMS) in Worcester. Expanding upon the vision and
success of M2D2, the goal of CAPCaT is to develop and optimize novel POCT to improve the
diagnosis and management of heart, lung, blood and sleep (HLBS) diseases. We have focused
on these diseases because of the significant morbidity, mortality, and cost associated with these
diseases. Combined, these diseases account for 41% of deaths in the US and lead to over
$400B in direct health care expenses plus lost income to affected patients and caregivers.
UMass has an established track record of clinical expertise and technology development in the
HLBS diseases. Our objectives are to: 1) identify, through stakeholder engagement, the most
promising POCTs to address unmet medical needs; 2) support developmental plans, including
pathways to adoption at the point of care; and 3) train and disseminate developing POCT to the
different stakeholders.
项目摘要/摘要--总体
美国医疗保健正在迅速演变为一种医疗保健的效率和质量
共同主导的驱动因素。几个新出现的趋势正在推动医疗保健领域的根本性变革:
1)越来越多的患者在责任护理组织中捆绑支付
提供者;2)强调质量指标,如减少心力衰竭的再入院和
改善对高血压的控制;以及3)更多地关注患者作为医疗保健的驱动力
决策和护理方面的伙伴。现在迫切需要开发出
向护理人员和患者提供快速反馈,以便及时改变
患者自我护理、症状检测、诊断和治疗交付。特别是,有一个
迫切需要新的循证、用户友好、以患者为中心的护理点技术
(POCT)监控人们在日常生活之外的健康/医疗状况
并向看护点提交可采取行动的报告。先进点的中心
心、肺、血液和睡眠疾病的护理技术(CAPCaT)将是
一个非常成功的医疗产品孵化器,马萨诸塞州医疗器械开发公司
马萨诸塞大学(洛厄尔校区和伍斯特校区)M2D2中心。这个
M2D2的创建目标是加速医疗器械的发展,使用
UMassLowell(统一建模语言)在工程和商业方面的综合专业知识,以及临床
位于伍斯特的UMMS医学院的专业知识。扩展远景和
M2D2的成功,CAPCaT的目标是开发和优化新型POCT,以提高
心、肺、血和睡眠(HLBS)疾病的诊断和治疗。我们已经专注于
由于与这些疾病相关的显著发病率、死亡率和成本
疾病。这些疾病加在一起,占美国死亡人数的41%,导致超过
4000亿美元的直接医疗费用加上受影响患者和照顾者的收入损失。
UMASS在临床专业知识和技术开发方面拥有成熟的记录
HLBS疾病。我们的目标是:1)通过利益相关者的参与,确定最
承诺提供方案以满足未得到满足的医疗需求;2)支持发展计划,包括
在护理地点采用的途径;以及3)培训和传播发展的POCT
不同的利益相关者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRYAN O BUCHHOLZ其他文献
BRYAN O BUCHHOLZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRYAN O BUCHHOLZ', 18)}}的其他基金
UMass Lowell Innovative Fellows Training (UMass LIFT)
麻省大学洛厄尔分校创新研究员培训(UMass LIFT)
- 批准号:
10741529 - 财政年份:2023
- 资助金额:
$ 156.25万 - 项目类别:
The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep Diseases
心脏、肺、血液和睡眠疾病护理点推进中心
- 批准号:
10735580 - 财政年份:2018
- 资助金额:
$ 156.25万 - 项目类别:
The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep Diseases
心脏、肺、血液和睡眠疾病护理点推进中心
- 批准号:
9766380 - 财政年份:2018
- 资助金额:
$ 156.25万 - 项目类别:
The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep Diseases
心脏、肺、血液和睡眠疾病护理点推进中心
- 批准号:
10450787 - 财政年份:2018
- 资助金额:
$ 156.25万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 156.25万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 156.25万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 156.25万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 156.25万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 156.25万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 156.25万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 156.25万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 156.25万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 156.25万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 156.25万 - 项目类别:
Standard Grant